EZH-301 (Sarcoma) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn more about the study drug, tazemetostat (also called EPZ-6438) and to find out the effectiveness and best dose for people with STS.
Soft-tissue sarcoma (STS), Advanced Epithelioid Sarcoma
Who Can Participate in the Study?
-Have a diagnosis of STS.
For more information on who can participate in this study please contact the study team.
What is Involved?
If you choose to join this study you will:
-Have physical exams
-Give blood samples,
-Have an Electrocardiogram and echocardiogram (To look your heart activity)
-Take the study drug (Tazemetostat) by mouth twice a day.
-Get the study drug (Doxorubicin) though your vein drug on the first day of your drug cycle (21 day cycles) for a maximum of 6 cycles
-Complete follow-up visits or phone calls every 3 months for up to 2 years